
Posted on February 6, 20252/6/25
Conserving Capital for Pharma Commercialization: Strategic Insights for Biotech Companies

Posted on January 22, 20251/22/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success

Posted on January 6, 20251/6/25
Beyond Theory: Integrated Commercialization Model Proves Valuable in Launch Success

Posted on December 19, 202412/19/24
Evaluating PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Matching-Adjusted Indirect Comparison

Posted on December 4, 202412/4/24
Successfully Navigating Global Commercialization- A View from the C-Suite and Global Commercial Leaders

Posted on November 19, 202411/19/24
A Review of Indirect Treatment Comparisons (ITCs) in Regulatory Approval, Reimbursement and Pricing Recommendations for Oncology Drugs

Posted on November 6, 202411/6/24
Adherence Redefined: Evolving Approaches to Adherence in Oncology Clinical Pathways

Posted on November 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA

Posted on October 25, 202410/25/24
New Insights into Brain Volume Loss in MS

Posted on October 15, 202410/15/24